Clinical Outcome and Biomarker Assessments of a Multi-Centre Phase II Trial Assessing Niraparib with or Without Dostarlimab in Recurrent Endometrial Carcinoma
Nature communications（2023）
关键词
Cancer immunotherapy,Drug development,Endometrial cancer,Targeted therapies,Science,Humanities and Social Sciences,multidisciplinary
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要